Blood Glucose Monitoring System Market

The report "Blood Glucose Monitor Market by Product Type (Self blood glucose monitoring, Professional point of care), Application (Diabetes management, Health & Wellness Monitoring), Test site (Fingertip, Upper arm), End User (Self/Homecare) - Global Forecast to 2030", is projected to reach 25.4 billion in 2030 from USD 16.5 billion in 2025, at a CAGR of 9.1% during the forecast period.

Browse 250 market data Tables and 60 Figures spread through 310 Pages and in-depth TOC on "Blood Glucose Monitor Market by Product Type (Self blood glucose monitoring, Professional point of care), Application (Diabetes management, Health & Wellness Monitoring), Test site (Fingertip, Upper arm), End User (Self/Homecare) - Global Forecast to 2030"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/blood-glucose-monitoring-system-market-14912252.html

One of the key factors driving the growth of the blood glucose monitor market is the rising prevalence of diabetes worldwide. Over the forecast period, increasing awareness about diabetes management and the growing focus on self-monitoring are expected to further support market expansion. Technological advancements such as continuous glucose monitoring (CGM), non-invasive sensors, smart connected devices, and AI-driven analytics are fueling growth by improving accuracy, convenience, and patient outcomes. However, high device costs, limited access in certain regions, and the learning curve associated with advanced technologies could moderately restrain market growth. Overall, the demand for blood glucose monitors is expected to remain strong, driven by innovation and the increasing emphasis on effective diabetes management.

Based on product type, the self-monitoring blood glucose systems segment accounted for the largest share in the blood glucose monitor market in 2024.

Based on product type, the global blood glucose monitor market is divided into four main segments: self-monitoring blood glucose systems, continuous glucose monitoring systems, Professional Point of care devices, and noninvasive products. The self-monitoring blood glucose systems segment accounted for the largest market share in 2024, supported by its low cost, ease of use, and strong penetration across both homecare and clinical settings. SMBG devices remain the standard method for routine glucose testing, particularly among patients in low- and middle-income countries where affordability and accessibility are key factors. The segment’s dominance is further reinforced by continuous product improvements, such as compact designs, faster testing strips, and better data storage features that enhance convenience and accuracy for daily diabetes management.

Based on application, the diabetes management segment is expected to grow at the highest CAGR during the forecast period in the blood glucose monitor market.

The global blood glucose monitor market is segmented by application into three categories: diabetes management, health & wellness monitoring, and other applications. The diabetes management segment is expected to grow at the highest CAGR during the forecast period. The increasing incidence of type 1 and type 2 diabetes globally has increased the demand for continuous monitoring, with the growing use of continuous glucose monitoring (CGM) systems offering real-time information for improved insulin therapy and lifestyle changes. Connectivity with digital health platforms enables easy tracking, reminders, and collaboration with healthcare professionals, enabling personalized care and customized treatment plans. In addition, regular and consistent monitoring allows for early intervention, allowing patients to have optimal glucose control and minimize the risk of severe diabetes complications. Moreover, government programs and insurance schemes encouraging early diagnosis and efficient diabetes control are facilitating broader utilization, with convenient home monitoring devices allowing patients to monitor their glucose level independently, enhancing treatment compliance.

North America is expected to dominate the global blood glucose monitor market during the forecast period.

The global market for blood glucose monitor is divided into six main regions: North America, Europe, Asia Pacific, Latin America, the Middle East & Africa, and the GCC Countries.

The market is dominated by North America based on its well-developed healthcare infrastructure, quick uptake of cutting-edge medical technologies, and high demand for efficient diabetes control solutions. The dominance of the region is further given by the fact that large market players and innovators in the blood glucose monitoring sector are based here. Moreover, high disposable incomes, extensive health consciousness, an increase in reimbursement policies, and a strong focus on preventive care in the US and Canada promote demand for precise and accurate glucose monitoring devices.

Key Players

Prominent players in the blood glucose monitor market include  Abbott Laboratories (US), Dexcom, Inc. (US), Medtronic (Ireland), B.Braun SE (Germany), F. Hoffmann-La Roche Ltd (Switzerland), Ascensia Diabetes Care Holdings AG (Switzerland), Senseonics (US), Nipro (Japan), Medical Technology and Devices S.p.A. (Italy), Terumo Corporation (Japan), i-SENS, Inc. (South Korea), Sinocare (China), Nemaura Medical Inc. (UK), ACON Laboratories, Inc. (US), LifeScan IP Holdings, LLC (US), Ultrahuman Healthcare Pvt Ltd. (India), LifePlus (US), Prodigy Diabetes Care, LLC (US), A. Menarini Diagnostics S.r.l (Italy), Beurer GmbH (Germany), Oura Health Oy (Finland), SD Biosensor, INC (South Korea), Agatsa (India), Rossmax International Ltd (US), and Medisana GmbH (Germany).

Don’t miss out on business opportunities in Blood Glucose Monitor Market. Speak to our analyst and gain crucial industry insights that will help your business grow.

About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/